Marta Rodriguez Alvarez, Presenter: Nothing to Disclose

M Carmen Saborido MD, Abstract Co-Author: Nothing to Disclose

Beatriz Baltar Nieto MD, Abstract Co-Author: Nothing to Disclose

Pablo Pazos, Abstract Co-Author: Nothing to Disclose

Amadeo Arango MD, Abstract Co-Author: Nothing to Disclose

Ana Maria Afonso, Abstract Co-Author: Nothing to Disclose

 We describe and review CMRI features in myocardial infarction. Evaluate CMRI endpoints with clinical and prognostic implication, with focusing on ischemia-reperfusion injury.  

 We review MRI findings of myocardial infarction, specially focusing on patients with AMI and reperfusion therapy.  We evaluate area at risk, infarct size,  salvaged myocardium and reperfusion injury and assess cardiac function and volumes. T2* CMR  detected  hemorrhage.   Infarct size and myocardial salvage are surrogate endpoints for mortality in the setting of myocardial infarction.  Regions of no enhancement  or maintained perfusion defects were areas of no-reflow, MO/hemorrhage. First-pass and early gadolinium enhancement  techniques are more sensitive than LGE. We detected MO in  patients with transmural infarcts or an affectation of at least 75% of  wall thickness. MRI is the best imaging technique to detect the presence of hemorrhage.   Infarct size, transmural infarction and persistent MO are strong predictors of adverse post-infarct remodeling over other clinical parameters.  MRI is especially adequately to study and follow up myocardial infarcts and its potential complications.        

http://abstract.rsna.org/uploads/2014/14017459/14017459_vbnq.pdf

Rodriguez Alvarez, M, Saborido, M, Nieto, B, Pazos, P, Arango, A, Afonso, A, MRI in Myocardial Infarction: Ischemia-reperfusion Injury — Imaging Endpoints with Prognostic Value.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14017459.html